India betamethasone market is expected to grow at a steady rate during the forecast period. The India betamethasone market is driven by the widespread use of the drug for the treatment of a wide range of skin disorders including eczema, psoriasis, among others. Additionally, the increasing use of the medication in several rheumatic disorders such as rheumatoid arthritis, systemic lupus erythematosus, among others is further expected to fuel the market growth over the next few years. Besides, benefits such as easy availability and administration through different routes of administration such as oral, intravenous and topical are further expected to positively influence the market growth through FY2026. Also, the betamethasone cream and ointment are a part of the WHO’s list of essential medicines.
The India betamethasone market is segmented based on source, type, form, route of administration, distribution channel, application, end user, company and region. Based on distribution channel, the market can be split into online and offline. The offline channel is expected to dominate the market owing to the consumer preference for buying medicines from a pharmacy or drug store.
The major players operating in the India betamethasone market are Envee Drugs Pvt. Ltd., GlaxoSmithKline Pharmaceuticals Ltd, Dermocare Laboratories (Guj.) Pvt Ltd, Emson Medichem Pvt. Ltd, Cipla Limited, East West Pharma, Omega Remedies Pvt Ltd, Moraceae Pharmaceuticals Pvt. Ltd., Micro Labs Ltd, Pharmtak Ophtalmics Pvt. Ltd. and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.
Years considered for this report
Historical YearsFY2016-FY2019
Base YearFY2020
Estimated YearFY2021
Forecast PeriodFY2022–FY2026
Objective of the Study
- To analyze and estimate the market size of India betamethasone market from FY2016 to FY2019.
- To estimate and forecast the market size of India betamethasone market from FY2020 to FY2026 and growth rate until FY2026.
- To classify and forecast India betamethasone market based on source, type, form, route of administration, distribution channel, application, end user, company and regional distribution.
- To identify dominant region or segment in the India betamethasone market.
- To identify drivers and challenges for India betamethasone market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India betamethasone market.
- To identify and analyze the profile of leading players operating in India betamethasone market.
- To identify key sustainable strategies adopted by market players in India betamethasone market.
Click here to download the sample
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.
TechSci Research calculated the market size of
Key Target Audience
- Betamethasone manufacturers/ suppliers/ distributors
- Market research and consulting firms
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to betamethasone
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
